Vivos Inc (RDGL)

[mc73]

Agree with everything you say up to the point where you think RDGL needs to get more aggressive with IsoPet. To me, it is clear as day, there would have been less errors had they focused more on IDE and less in IsoPet; not to mention IsoPet generates $0 for RDGL (unless you count the chump change it generated last year, which I do not).

For shareholders that care about making money, IDE submission is the ONLY way forward. Mark these words: if RDGL doesn't submit the IDE by the end of June, the share price will crash. Also, if the VX2 report information (plus all other required data requested by the FDA) isn't included in the IDE submission and the IDE gets rejected - the share price will crash.

EVERYTHING is dependent on IDE submission and approval. I think they should have had a final meeting with the FDA to ensure they don't need further tests since they didn't tell us coming out of the last meeting with the FDA that it was the last one and the FDA told them they just needed to finalize this last round of tests and then submit.

Time will tell how this plays out. Hopefully RDGL can meet the Q2 submission timeline they keep saying they will make but just like many other things here, they have a habit of missing the deadlines they put out. Case in point - the Benzinga article.